Cytox – Role of mTOR pathway as a marker of...

Development of Cytox’s novel blood-based mTOR assay highlighted at Copenhagen, DK meeting, Thursday July 17, 2014 Manchester, UK, (Cytox) a leading developer of assays for risk assessment and prediction of dementia, announced the timing of a presentation discussing the development of a novel proprietary blood-based assay for the assessment of risk of cognitive decline. The…

read more

Blog

Invested Business? Invest in Marketing

With so much research and development taking place in the early stages of your...

read more

Planning for reopening – how to accelerate out of lockdown

The government’s roadmap out of the lockdown is currently going to plan and we...

read more
Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×